Lgt Capital Partners Ltd. Merck & Co., Inc. Transaction History

Lgt Capital Partners Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 07, 2019	SELL	$76.08 - $82.93 $4.12 Million - $4.49 Million	-54,120 Closed	0 $0
Q1 2019 Apr 11, 2019	SELL	$69.58 - $79.36 $3.94 Million - $4.5 Million	-56,660 Reduced 51.15%	54,120 $4.5 Million
Q4 2018 Jan 14, 2019	SELL	$65.24 - $75.71 $44.1 Million - $51.2 Million	-676,670 Reduced 85.93%	110,780 $8.47 Million
Q3 2018 Oct 18, 2018	SELL	$57.69 - $67.84 $6.35 Million - $7.46 Million	-110,007 Reduced 12.26%	787,450 $55.9 Million
Q2 2018 Jul 13, 2018	BUY	$50.83 - $59.72 $7.36 Million - $8.65 Million	144,857 Added 19.25%	897,457 $54.5 Million
Q1 2018 Apr 12, 2018	BUY	$50.96 - $59.23 $2.55 Million - $2.97 Million	50,120 Added 7.13%	752,600 $41 Million
Q4 2017 Jan 11, 2018	BUY	$51.62 - $61.64 $6.86 Million - $8.2 Million	132,990 Added 23.35%	702,480 $39.5 Million
Q3 2017 Oct 11, 2017	BUY	$58.67 - $63.13 $33.4 Million - $36 Million	569,490	569,490 $36.5 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Lgt Capital Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Lgt Capital Partners Ltd. with notifications on news.